Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis

Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However, DAPT duration is a concern in high bleeding risk (HBR) patients. We evaluated the effect of short DAPT (1-3 months) compared to standa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one Jg. 18; H. 9; S. e0291061
Hauptverfasser:	Bainey, Kevin R., Marquis-Gravel, Guillaume, MacDonald, Blair J., Bewick, David, Yan, Andrew, Turgeon, Ricky D.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	San Francisco Public Library of Science 01.09.2023 Public Library of Science (PLoS)
Schlagworte:	Acute coronary syndromes Aggregation Angioplasty Anticoagulants Antiplatelet therapy Bias Bleeding Blood clot Blood platelets Cardiovascular diseases Care and treatment Clinical trials Confidence intervals Consortia Health risks Heart attacks Implants Intervention Ischemia Medicine and Health Sciences Meta-analysis Mortality Patient outcomes Physical Sciences Prevention Research and Analysis Methods Risk assessment Stents Systematic review Thromboembolism Thrombosis Canada
ISSN:	1932-6203, 1932-6203
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!